395 related articles for article (PubMed ID: 10713693)
1. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
[TBL] [Abstract][Full Text] [Related]
2. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
3. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
[TBL] [Abstract][Full Text] [Related]
4. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
5. Possible role of Stat5a in rat mammary gland carcinogenesis.
Shan L; Yu M; Clark BD; Snyderwine EG
Breast Cancer Res Treat; 2004 Dec; 88(3):263-72. PubMed ID: 15609129
[TBL] [Abstract][Full Text] [Related]
6. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
7. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
8. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
Tomblyn S; Langenheim JF; Jacquemart IC; Holle E; Chen WY
Int J Oncol; 2005 Nov; 27(5):1381-9. PubMed ID: 16211235
[TBL] [Abstract][Full Text] [Related]
9. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
Lane TF; Leder P
Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
[TBL] [Abstract][Full Text] [Related]
10. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone increases Stat5 and Stat1 expression in lactating goat mammary gland: a specific effect compared to milking frequency.
Boutinaud M; Jammes H
Domest Anim Endocrinol; 2004 Nov; 27(4):363-78. PubMed ID: 15519040
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.
Welte T; Garimorth K; Philipp S; Doppler W
Mol Endocrinol; 1994 Aug; 8(8):1091-102. PubMed ID: 7527899
[TBL] [Abstract][Full Text] [Related]
14. Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b.
Liu X; Gallego MI; Smith GH; Robinson GW; Hennighausen L
Cell Growth Differ; 1998 Sep; 9(9):795-803. PubMed ID: 9751123
[TBL] [Abstract][Full Text] [Related]
15. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
Liu X; Robinson GW; Hennighausen L
Mol Endocrinol; 1996 Dec; 10(12):1496-506. PubMed ID: 8961260
[TBL] [Abstract][Full Text] [Related]
16. Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene.
Flint DJ; Boutinaud M; Whitelaw CB; Allan GJ; Kolb AF
J Mol Endocrinol; 2006 Jun; 36(3):435-48. PubMed ID: 16720715
[TBL] [Abstract][Full Text] [Related]
17. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional changes underlying the secretory activation phase of mammary gland development.
Naylor MJ; Oakes SR; Gardiner-Garden M; Harris J; Blazek K; Ho TW; Li FC; Wynick D; Walker AM; Ormandy CJ
Mol Endocrinol; 2005 Jul; 19(7):1868-83. PubMed ID: 15705664
[TBL] [Abstract][Full Text] [Related]
19. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
20. Expression by transgenesis of a constitutively active mutant form of the prolactin receptor induces premature abnormal development of the mouse mammary gland and lactation failure.
Gourdou I; Paly J; Hue-Beauvais C; Pessemesse L; Clark J; Djiane J
Biol Reprod; 2004 Mar; 70(3):718-28. PubMed ID: 14613905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
